Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies

Blood (2024) 143 (14): 1414–1424.

https://doi.org/10.1182/blood.2023022457

Published: 2024

Includes: Supplemental data

Journal Articles

A novel VWF-associated thrombolytic agent

Frank W. G. Leebeek

Blood (2022) 140 (26): 2770–2771.

https://doi.org/10.1182/blood.2022018024

Published: 2022

Journal Articles

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Frank W. G. Leebeek, Flora Peyvandi, Miguel Escobar, Andreas Tiede, Giancarlo Castaman, Michael Wang, Tung Wynn, Jovanna Baptista, Yi Wang, Jingmei Zhang, Björn Mellgård, Gülden Özen

Blood (2022) 140 (2): 89–98.

https://doi.org/10.1182/blood.2021014810

Published: 2022

Includes: Supplemental data

Journal Articles

Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues

Frank W. G. Leebeek, Wolfgang Miesbach

Blood (2021) 138 (11): 923–931.

https://doi.org/10.1182/blood.2019003777

Published: 2021

Journal Articles

How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease

Frank W. G. Leebeek, Johannes Duvekot, Marieke J. H. A. Kruip

Blood (2020) 136 (19): 2143–2150.

https://doi.org/10.1182/blood.2019000964

Published: 2020

Journal Articles

A prothrombotic von Willebrand factor variant

Frank W. G. Leebeek

Blood (2019) 133 (4): 288–289.

https://doi.org/10.1182/blood-2018-11-883488

Published: 2019

Journal Articles

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig, Erhard Seifried, Federica Cattaneo, Christian Meyer, Frank W. G. Leebeek

Blood (2018) 131 (9): 1022–1031.

https://doi.org/10.1182/blood-2017-09-804419

Published: 2018

Includes: Supplemental data

Journal Articles

Low VWF: an established mild bleeding disorder?

Frank W. G. Leebeek, Johan Boender

Blood (2017) 130 (21): 2241–2242.

https://doi.org/10.1182/blood-2017-09-807180

Published: 2017

Journal Articles

Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia

Eduard J. Libourel, Clara P. W. Klerk, Yvette van Norden, Moniek P. M. de Maat, Marieke J. Kruip, Pieter Sonneveld, Bob Löwenberg, Frank W. G. Leebeek

Blood (2016) 128 (14): 1854–1861.

https://doi.org/10.1182/blood-2016-02-701094

Published: 2016

Journal Articles

Natural heterogeneity of α2-antiplasmin: functional and clinical consequences

Shiraazkhan Abdul, Frank W. G. Leebeek, Dingeman C. Rijken, Shirley Uitte de Willige

Blood (2016) 127 (5): 538–545.

https://doi.org/10.1182/blood-2015-09-670117

Published: 2016

Journal Articles

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke

Michelle A. H. Sonneveld, Moniek P. M. de Maat, Marileen L. P. Portegies, Maryam Kavousi, Albert Hofman, Peter L. Turecek, Hanspeter Rottensteiner, Fritz Scheiflinger, Peter J. Koudstaal, M. Arfan Ikram, Frank W. G. Leebeek

Blood (2015) 126 (25): 2739–2746.

https://doi.org/10.1182/blood-2015-05-643338

Published: 2015

Includes: Supplemental data

Journal Articles

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

Joan C. Gill, Giancarlo Castaman, Jerzy Windyga, Peter Kouides, Margaret Ragni, Frank W. G. Leebeek, Ortrun Obermann-Slupetzky, Miranda Chapman, Sandor Fritsch, Borislava G. Pavlova, Isabella Presch, Bruce Ewenstein

Blood (2015) 126 (17): 2038–2046.

https://doi.org/10.1182/blood-2015-02-629873

Published: 2015

Journal Articles

Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

Paul S. de Vries, Johan Boender, Michelle A. H. Sonneveld, Fernando Rivadeneira, M. Arfan Ikram, Hanspeter Rottensteiner, Albert Hofman, André G. Uitterlinden, Frank W. G. Leebeek, Oscar H. Franco, Abbas Dehghan, Moniek P. M. de Maat

Blood (2015) 125 (25): 3949–3955.

https://doi.org/10.1182/blood-2015-02-629865

Published: 2015

Includes: Supplemental data

Journal Articles

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease

Yvonne V. Sanders, Dafna Groeneveld, Karina Meijer, Karin Fijnvandraat, Marjon H. Cnossen, Johanna G. van der Bom, M. Coppens, Joke de Meris, Britta A. P. Laros-van Gorkom, Eveline P. Mauser-Bunschoten, Frank W. G. Leebeek, Jeroen Eikenboom, the WiN study group

Blood (2015) 125 (19): 3006–3013.

https://doi.org/10.1182/blood-2014-09-603241

Published: 2015

Includes: Supplemental data

Journal Articles

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Jan Astermark, Paul P. Brons, Giancarlo Castaman, Marjon H. Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak, Daniel P. Hart, Charles R. M. Hay, Saturnino Haya, Waander L. van Heerde, Cedric Hermans, Margareta Holmström, Victor Jimenez-Yuste, Russell D. Keenan, Robert Klamroth, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Ri Liesner, Anne Mäkipernaa, Christoph Male, Evelien Mauser-Bunschoten, Maria G. Mazzucconi, Simon McRae, Karina Meijer, Michael Mitchell, Massimo Morfini, Marten Nijziel, Johannes Oldenburg, Kathelijne Peerlinck, Pia Petrini, Helena Platokouki, Sylvia E. Reitter-Pfoertner, Elena Santagostino, Piercarla Schinco, Frans J. Smiers, Berthold Siegmund, Annarita Tagliaferri, Thynn T. Yee, Pieter Willem Kamphuisen, Johanna G. van der Bom, Karin Fijnvandraat

Blood (2013) 122 (11): 1954–1962.

https://doi.org/10.1182/blood-2013-02-483263

Published: 2013

Includes: Supplemental data

Journal Articles

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

Jasper H. Smalberg, Lidia R. Arends, Dominique C. Valla, Jean-Jacques Kiladjian, Harry L. A. Janssen, Frank W. G. Leebeek

Blood (2012) 120 (25): 4921–4928.

https://doi.org/10.1182/blood-2011-09-376517

Published: 2012

Includes: Supplemental data

Journal Articles

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis

Jasper H. Smalberg, Edith Koehler, Sarwa Darwish Murad, Aurelie Plessier, Susana Seijo, Jonel Trebicka, Massimo Primignani, Moniek P. M. de Maat, Juan-Carlos Garcia-Pagan, Dominique C. Valla, Harry L. A. Janssen, Frank W. G. Leebeek, for the European Network for Vascular Disorders of the Liver (EN-Vie)

Blood (2011) 117 (15): 3968–3973.

https://doi.org/10.1182/blood-2010-11-319087

Published: 2011

Includes: Supplemental data

Journal Articles

Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease

Marianne C. van Schie, Moniek P. M. de Maat, Aaron Isaacs, Cornelia M. van Duijn, Jaap W. Deckers, Diederik W. J. Dippel, Frank W. G. Leebeek

Blood (2011) 117 (4): 1393–1399.

https://doi.org/10.1182/blood-2010-03-273961

Published: 2011

Includes: Supplemental data

Journal Articles

High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study

Eduard J. Libourel, Pieter Sonneveld, Bronno van der Holt, Moniek P. M. de Maat, Frank W. G. Leebeek

Blood (2010) 116 (1): 22–26.

https://doi.org/10.1182/blood-2009-12-257519

Published: 2010

Journal Articles

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome

Jildou Hoekstra, Ana H. C. Guimarães, Frank W. G. Leebeek, Sarwa Darwish Murad, Joyce J. M. C. Malfliet, Aurelie Plessier, Manuel Hernandez-Guerra, Philippe Langlet, Elwyn Elias, Jonel Trebicka, Massimo Primignani, Juan-Carlos Garcia-Pagan, Dominique C. Valla, Dingeman C. Rijken, Harry L. A. Janssen, for the European Network for Vascular Disorders of the Liver (EN-Vie)

Blood (2010) 115 (2): 388–395.

https://doi.org/10.1182/blood-2009-03-211557

Published: 2010

Includes: Supplemental data

NARROW

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies

A novel VWF-associated thrombolytic agent

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results

Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues

How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease

A prothrombotic von Willebrand factor variant

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Low VWF: an established mild bleeding disorder?

Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia

Natural heterogeneity of α2-antiplasmin: functional and clinical consequences

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis

Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease

High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only